Waverley Pharma (WAVE) Stock Statistics & Valuation Metrics

Waverley Pharma has a market cap or net worth of CAD 540.00K. The enterprise value is CAD 4.91M.

Market Cap

CAD 540.00K

Enterprise Value

CAD 4.91M

Waverley Pharma has 54,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

54,000,000

Owned by Insiders

―

Owned by Institutions

―

Waverley Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

―

Employee Count

0

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Waverley Pharma had revenue of ― and earned -1,078 in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-1,078

Pretax Income

―

Net Income

-1,078

EBITDA

-1,078

Earnings Per Share (EPS)

―

Beta

0.91

52-Week Price Change

-50.00%

50-Day Moving Average

0.01

200-Day Moving Average

0.01

Relative Strength Index (RSI)

6.67

Average Volume (3m)

10.30K

Waverley Pharma upcoming earnings date is Nov 20, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 27, 2026

Next Earnings Date

Nov 20, 2026

Ex-Dividend Date

―

Waverley Pharma has ― in cash and marketable securities with CAD 40.00K in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 40.00K

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Waverley Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

-6.23%

EPS Growth Forecast

-86.49%